CARAVITA, Sergio
 Distribuzione geografica
Continente #
EU - Europa 6.808
NA - Nord America 1.933
AS - Asia 1.859
SA - Sud America 530
AF - Africa 130
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 11.268
Nazione #
IE - Irlanda 2.893
US - Stati Uniti d'America 1.821
RU - Federazione Russa 1.292
SG - Singapore 984
GB - Regno Unito 966
NL - Olanda 621
CN - Cina 455
BR - Brasile 434
IT - Italia 428
FR - Francia 297
VN - Vietnam 186
ZA - Sudafrica 107
DE - Germania 94
CA - Canada 83
SE - Svezia 81
ID - Indonesia 56
HK - Hong Kong 42
AR - Argentina 36
FI - Finlandia 35
PL - Polonia 34
IN - India 28
MX - Messico 22
KR - Corea 21
EC - Ecuador 20
AT - Austria 17
BD - Bangladesh 17
PY - Paraguay 11
TR - Turchia 11
ES - Italia 10
UA - Ucraina 10
CO - Colombia 9
PK - Pakistan 9
IQ - Iraq 8
BG - Bulgaria 6
JP - Giappone 6
LT - Lituania 6
PE - Perù 6
UZ - Uzbekistan 6
BE - Belgio 5
EG - Egitto 5
EU - Europa 5
KE - Kenya 5
CL - Cile 4
IR - Iran 4
VE - Venezuela 4
AU - Australia 3
AZ - Azerbaigian 3
BO - Bolivia 3
ET - Etiopia 3
JM - Giamaica 3
KG - Kirghizistan 3
MA - Marocco 3
SA - Arabia Saudita 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
IL - Israele 2
LB - Libano 2
NO - Norvegia 2
NP - Nepal 2
RO - Romania 2
TN - Tunisia 2
BB - Barbados 1
BW - Botswana 1
CR - Costa Rica 1
CV - Capo Verde 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
HR - Croazia 1
JO - Giordania 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
QA - Qatar 1
RE - Reunion 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
ZM - Zambia 1
Totale 11.268
Città #
Dublin 2.863
Southend 840
Moscow 453
Ashburn 371
Singapore 365
Hefei 208
Princeton 171
Johannesburg 101
Boardman 99
New York 93
Chandler 90
The Dalles 86
Los Angeles 78
Ho Chi Minh City 73
Altamura 70
Beijing 69
Milan 58
Toronto 57
Washington 49
Wilmington 46
Fairfield 45
Buffalo 44
Jakarta 42
Redondo Beach 41
São Paulo 39
Hong Kong 38
Dalmine 35
Hanoi 33
London 30
Ogden 27
Chicago 24
Frankfurt am Main 23
Munich 22
Bergamo 19
Lappeenranta 19
Amsterdam 18
Nuremberg 18
Reggio Calabria 18
Dallas 16
Seoul 16
Rio de Janeiro 15
Rome 15
Montreal 14
Da Nang 13
Norwalk 13
Shenzhen 13
Guangzhou 12
Mexico City 12
Pune 12
Shanghai 12
Warsaw 12
Denver 11
Helsinki 11
San Diego 11
Woodbridge 11
Andover 10
Ankara 10
Brooklyn 10
Brasília 9
Cambridge 9
Curitiba 9
Poplar 9
Ribeirão Preto 9
Stockholm 9
Assago 8
Atlanta 8
Bologna 8
Guayaquil 8
Hangzhou 8
Portsmouth 8
San Francisco 8
Biên Hòa 7
Boston 7
Chiswick 7
Hounslow 7
Kilburn 7
Lauterbourg 7
Manchester 7
Palermo 7
Vienna 7
Belo Horizonte 6
Campinas 6
Chennai 6
Dhaka 6
Houston 6
Lima 6
Manaus 6
Quito 6
Santa Clara 6
Seattle 6
Bexley 5
Brusaporto 5
Brussels 5
Modena 5
Orem 5
Phoenix 5
Prescot 5
Salt Lake City 5
Sofia 5
Sorbolo 5
Totale 7.307
Nome #
Haemodynamic characteristics of COVID-19 patients with acute respiratory distress syndrome requiring mechanical ventilation. An invasive assessment using right heart catheterization 186
Haemodynamic validation of the three-step HFA-PEFF algorithm to diagnose heart failure with preserved ejection fraction 164
Clinical Value of a Novel Three-Dimensional Echocardiography–Derived Index of Right Ventricle–Pulmonary Artery Coupling in Tricuspid Regurgitation 146
Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: A meta-analysis 146
Pulmonary hypertension due to a stiff left atrium: Speckle tracking equivalents of large V-waves 137
Right Heart Adaptation to Exercise in Pulmonary Hypertension: An Invasive Hemodynamic Study 136
Upward shift and steepening of the blood pressure response to exercise in hypertensive subjects at high altitude 136
Cluster analysis of advanced invasive hemodynamics in heart failure with preserved ejection fraction 135
Cardiac magnetic resonance in heart failure with preserved ejection fraction: myocyte, interstitium, microvascular, and metabolic abnormalities 135
Do the remodeling effects of sacubitril/valsartan treatment depend upon heart failure duration? 134
Systemic Sclerosis and Pulmonary Hypertension: The Great Masquerader 134
Blood pressure at high altitude: Physiology and clinical implications 134
Current Limitations of Invasive Exercise Hemodynamics for the Diagnosis of Heart Failure with Preserved Ejection Fraction 134
Impact of COVID-19 on exercise pathophysiology: A combined cardiopulmonary and echocardiographic exercise study 133
Understanding mechanisms of Fontan failure: exercise haemodynamics to unmask diastolic dysfunction, again! 132
Interatrial Shunt Devices 129
Ambulatory Blood Pressure in Untreated and Treated Hypertensive Patients at High Altitude: The High Altitude Cardiovascular Research-Andes Study 129
Hyperparathyroidism in celiac disease: always secondary? 128
Decreased pulmonary vascular distensibility in adolescents conceived by in vitro fertilization 127
Intravenous iron therapy improves the hypercapnic ventilatory response and sleep disordered breathing in chronic heart failure 126
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years 126
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison 126
The right side of the circulation in not secondary heart failure with preserved ejection fraction: an elephant in the room? 126
Management of anticoagulant therapy in the follow-up of pulmonary embolism in clinical practice 125
The Added Value of 3-Dimensional Echocardiography to Understand the Pathophysiology of Functional Tricuspid Regurgitation 125
Hemodynamic phenotyping of pulmonary hypertension in left heart failure 125
Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation 124
Impact of correcting the 2D PISA method on the quantification of functional tricuspid regurgitation severity 124
Pulmonary congestion at rest and abnormal ventilation during exercise in chronic systolic heart failure 124
Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component 124
Acute high-altitude exposure reduces lung diffusion: Data from the HIGHCARE Alps project 124
Concomitant Transcatheter Edge-to-Edge Treatment of Secondary Tricuspid and Mitral Regurgitation: An Expert Opinion 122
Pulmonary arterial hypertension associated with a von Hippel-Lindau gene mutation 121
Blood pressure response to six-minute walk test in hypertensive subjects exposed to high altitude: Effects antihypertensive combination treatment 121
Impact of COVID-19 lockdown on exercise capacity in PAH patients 119
Incremental Value of Right Atrial Strain Analysis to Predict Atrial Fibrillation Recurrence after Electrical Cardioversion 119
Takayasu arteritis with aortic coarctation and multiple stenosis of aortic branches 119
Ischemic changes in exercise ECG in a hypertensive subject acutely exposed to high altitude. Possible role of a high-altitude induced imbalance in myocardial oxygen supply-demand 119
Atrial Functional Tricuspid Regurgitation as a Distinct Pathophysiological and Clinical Entity: No Idiopathic Tricuspid Regurgitation Anymore 118
An updated meta-analysis of hemodynamics markers of prognosis in patients with pulmonary hypertension due to left heart disease 117
Proposta di una lettera di dimissione standardizzata dopo ospedalizzazione per embolia polmonare acuta 117
Noninvasive versus invasive pressure–flow relationship of the pulmonary circulation: Bias and error 117
CPET for Long COVID-19 115
Assessment of left ventricular diastolic function by three-dimensional transthoracic echocardiography 115
Reply to: ‘The hyperdynamic circulatory profile of patients with COVID-19-related acute vascular distress syndrome’ 114
Pulmonary arterial hypertension 114
Current gaps in HFpEF trials: Time to reconsider patients' selection and to target phenotypes 114
Long-term effects of intermittent Iloprost infusion on pulmonary arterial pressure in connective tissue disease 112
Association of outcome with left ventricular volumes and ejection fraction measured with two- and three-dimensional echocardiography in patients referred for routine, clinically indicated studies 111
Heart failure and sleep related breathing disorders: Data from PROMISES (Progetto Multicentrico Italiano Sonno e Scompenso Cardiaco) study 110
Ipertensione polmonare pre-capillare o post-capillare? Il ruolo dei test provocativi in sala di emodinamica = Pulmonary hypertension: pre- or post-capillary? The role of provocative tests in the cath lab 109
Do Existing Definitions Identify Subgroup Phenotypes or Reflect the Natural History of Heart Failure with Preserved Ejection Fraction? 109
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 109
Recent advances in multimodality imaging of the tricuspid valve 108
Shedding Light on Latent Pulmonary Vascular Disease in Heart Failure With Preserved Ejection Fraction 108
The Conundrum of HFpEF Definition: Non-Invasive Assessment Uncertainties and Alternative Diagnostic Strategies 107
Diagnostic and therapeutic models for the management of acute pulmonary embolism: An issue of local available resources 107
Impact of severe secondary tricuspid regurgitation on rest and exercise hemodynamics of patients with heart failure and a preserved left ventricular ejection fraction 106
Invasive Hemodynamics of Hypertrophic Cardiomyopathy: Exercise Versus Isoproterenol 105
Pulmonary hypertension and ventilation during exercise: Role of the pre-capillary component 105
Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set 104
Corrigendum: The atrial secondary tricuspid regurgitation is associated to more favorable outcome than the ventricular phenotype 104
Pulmonary artery wedge pressure and left ventricular end-diastolic pressure during exercise in patients with dyspnoea 104
Exercise stress echocardiography of the pulmonary circulation and right ventricular-arterial coupling in healthy adolescents 104
Phenotyping long COVID 104
The added value of right ventricular function normalized for afterload to improve risk stratification of patients with pulmonary arterial hypertension 103
Obstructive Ventilatory Disorder in Heart Failure—Caused by the Heart or the Lung? 103
Stiff left atrial syndrome after low-dose radiotherapy for right breast cancer: The need for invasive hemodynamics at exercise 103
Statement ANMCO: Tromboembolismo arterioso e venoso: quali implicazioni per la pratica clinica? 102
Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database 102
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 101
Blood pressure response in miners exposed to chronic intermittent hypoxia in Chile 101
Right heart chambers geometry and function in patients with the atrial and the ventricular phenotypes of functional tricuspid regurgitation 101
Pulmonary arterial hypertension-associated genetic variants in combined post-capillary and pre-capillary pulmonary hypertension: a case report 100
Improvement of functional capacity in sacubitril-valsartan treated patients assessed by cardiopulmonary exercise test 99
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction 99
Pulmonary vascular function and exercise capacity in black sub-Saharan Africans 98
ANMCO Position paper: Pulmonary circulation diseases and COVID-19 98
Corrigendum to “Long-term prognostic role of diabetes mellitus and glycemic control in heart failure patients with reduced ejection fraction: Insights from the MECKI Score database” [Int J Cardiol. 2020 Oct 15; 317: 103–110. PMID: 32360652] (International Journal of Cardiology (2020) 317 (103–110), (S0167527320312663), (10.1016/j.ijcard.2020.04.079)) 98
Heart failure with preserved ejection fraction and COVID-19: which comes first, the chicken or the egg? Letter regarding the article ‘Heart failure with preserved ejection fraction according to the HFA-PEFF score in COVID-19 patients: clinical correlates and echocardiographic findings’ 98
Why Do Exercise Hemodynamics Matter? 98
Sildenafil therapy for interferon-β-1a-induced pulmonary arterial hypertension: A case report 96
Central sleep apnea during continuous positive airway pressure therapy in obstructive sleep apnea patients: From the compliance to adaptation, maladaptation and reflexes 96
The atrial secondary tricuspid regurgitation is associated to more favorable outcome than the ventricular phenotype 95
Right ventricular reserve in cardiopulmonary disease: a simultaneous hemodynamic and three-dimensional echocardiographic study 94
Discrepancy in the Diagnosis of Heart Failure With Preserved Ejection Fraction Between Supine Versus Upright Exercise Hemodynamic Testing 93
Corrigendum to 'Acute high-altitude exposure reduces lung diffusion: Data from the HIGHCARE Alps Project' [Respir. Physiol. Neurobiol. 188, (2013), 223-228] 93
Heart failure and anemia: Effects on prognostic variables 92
Personalized exercise prescription as a tool for hypertension management and cardiovascular prevention: Evidence and pending issues 91
Sex and acetazolamide effects on chemoreflex and periodic breathing during sleep at altitude 91
Blood Pressure Response to Exercise in Hypertensive Subjects Exposed to High Altitude and Treatment Effects 89
A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function 88
Role of acetazolamide and telmisartan/nifedipine-GITS combination in antagonizing the blood pressure rise induced by high altitude exposure 87
Alterations of cardiovascular complexity during acute exposure to high altitude: A multiscale entropy approach 83
Exercise haemodynamics in heart failure with preserved ejection fraction: a systematic review and meta-analysis 82
Pulmonary Hypertension Associated with Left Heart Disease 78
Blood pressure and high altitude: physiological response and clinical management 75
Exercise in hypoxia: a model from laboratory to on-field studies 70
Pick Your Threshold: A Comparison Among Different Methods of Anaerobic Threshold Evaluation in Heart Failure Prognostic Assessment 69
Invasive haemodynamic assessment in heart failure with preserved ejection fraction 67
Totale 11.174
Categoria #
all - tutte 62.370
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.370


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 0 0 0 0 0 18
2021/20221.433 79 300 213 14 120 179 90 58 83 96 154 47
2022/2023882 179 133 168 81 28 43 26 58 44 17 77 28
2023/20243.546 47 53 101 68 87 711 2.216 86 56 5 4 112
2024/20252.975 102 248 85 356 99 32 29 122 363 796 400 343
2025/20262.795 224 324 564 867 771 45 0 0 0 0 0 0
Totale 11.649